Le Lézard
Classified in: Business
Subject: OFR

Frontenac Mortgage Investment Corporation amends its prospectus


SHARBOT LAKE, ON, Jan. 24, 2020 /CNW/ - Frontenac Mortgage Investment Corporation ("FMIC") obtained a receipt for an amendment to its prospectus dated January 21, 2019 relating to the continuous offering of its common shares.

Frontenac's prospectus dated January 21, 2019, as amended by prospectus amendment dated September 24, 2019, indicates that Frontenac will continue to distribute its common shares under its current investment funds prospectus in Form 41-101F2 until the earlier of (i) completion of the transition from an investment fund issuer to a corporate issuer, (ii) the net asset value of Frontenac exceeding $250 million, and (iii) the lapse date of Frontenac's current prospectus, being January 21, 2020.

The net asset value of Frontenac does not exceed $250 million and Frontenac has not yet completed its transition from an investment fund issuer to a corporate issuer. Frontenac has received regulatory approval to extend the lapse date of the Frontenac's prospectus from January 21, 2020 to March 31, 2020 in order to permit Frontenac to complete the transition from an investment fund issuer to a corporate issuer. Frontenac filed a second amendment to its prospectus to reflect the extension of the lapse date and has received a receipt for the second amendment to its prospectus. Frontenac's prospectus, as amended, now indicates that Frontenac will continue to distribute its common shares under its prospectus in Form 41-101F2 (prospectus form for investment funds) until the earlier of (i) completion of the transition from an investment fund issuer to a corporate issuer; (ii) the Net Asset Value of Frontenac exceeding $250 million; and (iii) the lapse date of Frontenac's Prospectus, being March 31, 2020.

SOURCE Frontenac Mortgage Investment Corporation


These press releases may also interest you

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:54
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Autodesk, Inc. ("Autodesk" or "the Company") and certain of its officers....

at 18:54
Cliffside Capital Ltd. ("Cliffside" or the "Company")  is pleased to announce financial results for the year ended December 31, 2023. The Company reported the following for 2023 compared with the prior year: Decline in gross finance receivables by...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: